Neurocrine Biosciences, Inc.

NBIXNASDAQHealthcare● Active

$163.88

$-3.47(-2.07%)

Market Cap$16.5B

P/E Ratio—

52W High$168

52W Low$122.14

Avg Volume1.2M

Open$167.53

Beta0.40

Overview

Neurocrine Biosciences, Inc. (NBIX) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

NBIX · net income · updated Jun 8, 2026

Core profitability metrics

NBIX · net income · margin · TTM · CAGR

Net income was $478.6M for FY2025 (fiscal year ending 2025-12-31), up 40.2% year-over-year. Net profit margin was 16.7%. Based on available data, Neurocrine Biosciences, Inc. has been profitable since at least 2011.

FY2025 Net Income$478.6M▲ +40.2% YoY

Trailing 12M (TTM)$668.6Mtrailing 4 quarters sum

Net Profit Margin16.7%$478.6M ÷ $2.86B

YoY Change+40.2%—

5-Year CAGR+3.3%FY2020 → FY2025

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2011

▸ FMP /income-statement · Annual · NBIX net income history · NBIX profit margin

Annual net income data

NBIX · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025$478.6M▲ +40.2%16.7%$2.86B

FY2024$341.3M▲ +36.7%14.5%$2.36B

FY2023$249.7M▲ +61.6%13.2%$1.89B

FY2022$154.5M▲ +72.4%10.4%$1.49B

FY2021$89.6M▼ 78.0%7.9%$1.13B

Net income vs peers (Healthcare)

NBIX vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

Neurocrine Biosciences, Inc.YOU

NBIX

$478.6M+40.2%16.7%

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

Neurocrine Biosciences, Inc. (NBIX) reported net income of $478.6M for FY2025 (fiscal year ending 2025-12-31), up 40.2% year-over-year. The net profit margin was 16.7% — meaning the company kept $0.17 of every dollar of revenue as profit.

Based on available data, Neurocrine Biosciences, Inc. has been profitable since at least 2011. Net income reached a peak of $478.6M in FY2025. Data available for 15 fiscal years.

Neurocrine Biosciences, Inc.'s net profit margin was 16.7% for FY2025, based on the latest annual results.

Investors sometimes search for "Neurocrine Biosciences, Inc. net worth" — the company's market capitalization is a separate figure from NBIX net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

NBIX net income · 5 questions

Neurocrine Biosciences, Inc. is profitable. The company reported net income of $478.6M for FY2025, a net profit margin of 16.7%. Net income was up 40.2% year-over-year. Based on available data, Neurocrine Biosciences, Inc. has been profitable since at least 2011.

is NBIX profitabledoes NBIX make a profitNBIX profitabilityNBIX profitable company

▸ Source: FMP /income-statement · GAAP · Neurocrine Biosciences, Inc. · Neurocrine Biosciences, Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026